Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share

v3.6.0.2
Earnings (Loss) Per Common Share
 6 Months Ended
Dec. 31, 2016
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
10.
Earnings (Loss) Per Common Share
 
Basic earnings (loss) per common share is computed by dividing the net income (loss) allocated to common stockholders by the weighted-average number of shares of common stock outstanding during the period. For purposes of calculating diluted earnings (loss) per common share, the denominator includes both the weighted-average number of shares of common stock outstanding during the period and the number of common stock equivalents if the inclusion of such common stock equivalents is dilutive. Dilutive common stock equivalents potentially include stock options and warrants using the treasury stock method. The following table summarizes the components of the earnings (loss) per common share calculation (in thousands, except per share amounts):  
 
 
 
Three Months ended
 
Six Months ended
 
 
 
December 31,
 
December 31,
 
 
 
2016
 
2015
 
2016
 
2015
 
Basic and diluted numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss available to iBio, Inc. stockholders
 
$
(3,229)
 
$
(2,246)
 
$
(6,290)
 
$
(4,051)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding
 
 
89,109
 
 
77,326
 
 
89,109
 
 
77,316
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per share amount
 
$
(0.04)
 
$
(0.03)
 
$
(0.07)
 
$
(0.05)
 
 
In Fiscal 2017 and Fiscal 2016, the Company incurred net losses which cannot be diluted; therefore, basic and diluted loss per common share are the same. As of December 31, 2016, shares issuable which could potentially dilute future earnings included approximately 12.3 million stock options.  As of December 31, 2015, shares issuable which could potentially dilute future earnings included approximately 12.1 million stock options and 1.8 million warrants.